Thank you, Niccolo, and thank you to everyone joining us today. Let's walk through this quarter's financial results in more detail. As Peter mentioned, we had an excellent fourth quarter, recognizing $11.7 million in revenue. For the full-year, we ended up with $43.1 million in revenue, above the high end of our updated guidance range and up 95% year-over-year. We had $22.9 million in bookings in the fourth quarter and ended the year with $95.6 million in total bookings, which was also above the high end of our updated guidance range for 2024 and up over 46% year-over-year. Moving down the income statement, for the fourth quarter of 2024, our total operating costs and expenses were $89.2 million, up 47% from $60.6 million in the prior year period. For the full-year of 2024, that number was $275.5 million, up 53% from $179.8 million in 2023. To break this down further, our research and development costs for the fourth quarter were $40.1 million, up 27% from $31.6 million in the prior year period. For the full-year of 2024, that number was $136.8 million, up 48% from $92.3 million in 2023. Recall that we are investing heavily in R&D and are investing in the production of our various product lines to meet projected customer demand. Our sales and marketing costs in the fourth quarter were $8.9 million, up 28% from $7 million in the prior year period. For the full-year of 2024, that number was $28.4 million, up 55% from $18.3 million in the full-year of 2023. This increase was due to us growing our go-to-market function as we continue the investment in our commercialization efforts, and we expect that trend to continue as we further expand our sales initiative. Our general and administrative costs in the fourth quarter were $29.7 million, up 94% from $15.3 million in the prior year period. For the full-year of 2024, that number was $71.1 million, up 40% from $50.7 million in the full-year of 2023. Stock-based compensation was $106.9 million for the full-year of 2024, up from $69.7 million in the full-year of 2023. All of this resulted in a net loss of $202 million in the fourth quarter, compared to $41.9 million in the prior year period, and a net loss of $331.6 million for the full-year of 2024 versus $157.8 million in 2023. It is important to note that these results include a non-cash loss of $128.5 million for the fourth quarter, related to the change in fair value of our warrant liabilities, and $117.1 million in non-cash loss for the full-year 2024. We saw an adjusted EBITDA loss for the fourth quarter of $32.8 million, compared to a $20 million loss in the prior year period, and a loss of $107.2 million for the full-year 2024 versus $77.7 million for 2023. Note that we projected an adjusted EBITDA loss for the full-year 2024 of $110.5 million, once again beating our expected plan. Turning now to our balance sheet, cash, cash equivalents, and investments as of December 31, 2024 were $363.8 million. I'm excited to share that IonQ is launching a $500 million at the market facility to equip IonQ with an even larger war chest. We plan to use the proceeds to accelerate our networking business and create new lines of growth in promising application areas. As the initial amount we raised when we were in public was largely sufficient for the computing business, we believe that this new amount of capital will provide us with a critical mass of capital for advancing in the quantum networking and communications business. Our capital needs are finite, and this is a unique moment for long-term investors to build a position at scale as we gear up for the era of quantum advantage. We are generating a strong foundation for what we expect will be another incredible year for IonQ. We aim to continue our growth once again in 2025. We are projecting revenue of between $75 million to $95 million for the full-year, and $7 million to $8 million in Q1. Our guidance includes all organic momentum and inorganic activity. Because of the early stage of the company's sales organization and the time it takes to turn a sale into revenue, we created the bookings metric back in 2021 to allow investors to gauge our progress. With revenue expected to be in the nine figures next year, 2026, we are sunsetting bookings guidance. We will, of course, continue to update the market on significant commercial milestones. Additionally, we anticipate an adjusted EBITDA loss of $120 million for the full-year 2025 at the midpoint of our revenue guidance. And with that, I would like to turn the call back over to Peter for some closing remarks.